Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer
Phase 1/2 Unknown
60 enrolled
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes
Phase 1/2 Unknown
45 enrolled
A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors
Phase 1/2 Unknown
130 enrolled
GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer
Phase 1/2 Unknown
10 enrolled
IPXELOX
Phase 1/2 Unknown
61 enrolled
YY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial
Phase 1/2 Unknown
28 enrolled
A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer
Phase 1/2 Unknown
56 enrolled
A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer
Phase 1/2 Unknown
106 enrolled
Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer
Phase 1/2 Unknown
23 enrolled
Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer
Phase 1/2 Unknown
54 enrolled
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Phase 1/2 Unknown
160 enrolled
SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer
Phase 1/2 Unknown
71 enrolled
Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer
Phase 1/2 Unknown
43 enrolled
Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
Phase 1/2 Unknown
54 enrolled
Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting
Phase 1/2 Unknown
45 enrolled
Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer
Phase 1/2 Unknown
42 enrolled
Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Phase 1/2 Unknown